Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(22E,24R)-6beta-methoxyergosta-7,9(11),22-triene-3beta,5alpha-diol | steroid from Ganoderma sinense. Potential drug candidate targeting at hexokinase 2 for cancer therapy | Homo sapiens | |
22E-6beta-methoxyergosta-7,22-diene-3beta,5alpha-diol | - |
Homo sapiens | |
Benserazide | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P52789 | - |
- |
Purification (Comment) | Organism |
---|---|
- |
Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
carcinoma cell | the enzyme is expressed at high level in cancer cells compared with normal cells | Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
hexokinase 2 | - |
Homo sapiens |
HK2 | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00206 | - |
pH and temperature not specified in the publication | Homo sapiens | (22E,24R)-6beta-methoxyergosta-7,9(11),22-triene-3beta,5alpha-diol | |
0.00552 | - |
pH and temperature not specified in the publication | Homo sapiens | Benserazide | |
0.01452 | - |
pH and temperature not specified in the publication | Homo sapiens | 22E-6beta-methoxyergosta-7,22-diene-3beta,5alpha-diol |
General Information | Comment | Organism |
---|---|---|
metabolism | rate-limiting enzyme in the first step of glycolysis pathway | Homo sapiens |